Grace Therapeutics (GRCE) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Grace Therapeutics (GRCE) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Grace Therapeutics

· GRCE

Dashboard

Financials

Ratios

Valuation

Statistics

44.386 M

+1.90%

General

Market Cap: $44.39M
Enterprise Value: $21.23M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -42.84%
ROE: -35.78%
ROIC: -48.75%
Current Ratio: 11.47
Debt-to-Equity: —
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: —
EV/EBITDA: -0.83

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $25.69M
Operating Income: -$25.69M
Net Profit: -$21.45M

Balance Sheet

Cash and Equivalents: $13.76M
Working Capital: $13.08M
Total Assets: $50.07M
Net Debt: -$13.76M
Total Liabilities: $1.86M
Total Equity: $48.21M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$10.3M
Cash Flow from Investing: —
Cash Flow from Financing: $4.04M
Free Cash Flow: -$10.3M
Capital Expenditures: $0